To the extent that they have deficient glucagon secretory responses to plasma glucose decrements, as they commonly do, patients with insulin-dependent diabetes mellitus (IDDM) are dependent on epinephrine-mediated β-adrenergic mechanisms to promote recovery from hypoglycemia. Thus, they are at in…